Delivery Order SPE2DB22D3016-SPE2DB26FABC5
Award Date 11/3/25
Potential Completion Date 11/25/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials valued at $6,092.18 with a completion date of November 10, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,540.39 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply under the company's existing indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,705.60 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials. The contract, awarded on September 29, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 21, 2025. This award was competitively solicited with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,963.20 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of November 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $55,852.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 ml vials on October 23, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 12, 2025, with completion scheduled for October 3, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the company's facility at the same location in Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,743.66 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 milliliter vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the delivery of an immunoglobulin...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 mL vials on August 15, 2025, with completion expected by September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $13,963.20 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immune globulin vial, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a routine medical supply transaction executed under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,327.20 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement needs,...